Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications.
about
Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretionPrognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cellsLow levels of cathepsin D are associated with a poor prognosis in endometrial cancer.
P2860
Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cathepsin D in breast cancer: ...... logy to clinical applications.
@en
Cathepsin D in breast cancer: ...... logy to clinical applications.
@nl
type
label
Cathepsin D in breast cancer: ...... logy to clinical applications.
@en
Cathepsin D in breast cancer: ...... logy to clinical applications.
@nl
prefLabel
Cathepsin D in breast cancer: ...... logy to clinical applications.
@en
Cathepsin D in breast cancer: ...... logy to clinical applications.
@nl
P2093
P1476
Cathepsin D in breast cancer: ...... logy to clinical applications.
@en
P2093
P304
P577
1990-12-01T00:00:00Z